Whitefort Capital Management, LP Q4 2024 Filing

Filed February 14, 2025

Portfolio Value

$209.0B

Holdings

18

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (18 positions)

#StockSharesValue% PortfolioType
1
I9DNARBUTUS BIOPHARMA CORP
13,241,916$43.3B20.72%
2
ROIVROIVANT SCIENCES LTD
2,391,000$28.3B13.54%
3
LQDALIQUIDIA CORPORATION
1,987,245$23.4B11.18%
4
GNWGENWORTH FINL INC
2,986,960$20.9B9.99%
5
CDZICADIZ INC
3,719,951$19.3B9.26%
6
JOYYJOYY INC
420,427$17.6B8.42%
7
0C3ENDEAVOR GROUP HLDGS INC
500,000$15.6B7.49%
8
KK0NEXTNAV INC
629,590$9.8B4.69%
9
GSLGLOBAL SHIP LEASE INC NEW
369,768$8.1B3.86%
10
ESPR 4 11/15/25ESPERION THERPEUTICS INC NE
8,000,000$7.8B3.72%
11
SABHLD 4 04/15/25SABRE GLBL INC
5,000,000$4.9B2.36%
12
VATE 7.5 08/01/26 *INNOVATE CORP
12,218,000$4.2B1.99%
13
MHLAMAIDEN HOLDINGS LTD
1,997,005$3.4B1.62%
14
VATEINNOVATE CORP
320,131$1.6B0.76%
15
NNAVWNEXTNAV INC
100,880$579.1M0.28%
16
OPKOPKO HEALTH INC
134,490$197.7M0.09%
17
TRIBTRINITY BIOTECH PLC
81,902$72.1M0.03%
18
AEAEWALTENERGY ACQUISITION CORP
186,315$783K0.00%